These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
257 related items for PubMed ID: 19491037
1. Expression and activity of the efflux transporters ABCB1, ABCC2 and ABCG2 in the human colorectal carcinoma cell line LS513. Salphati L, Plise EG, Li G. Eur J Pharm Sci; 2009 Jun 28; 37(3-4):463-8. PubMed ID: 19491037 [Abstract] [Full Text] [Related]
2. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology. Andersen V, Svenningsen K, Knudsen LA, Hansen AK, Holmskov U, Stensballe A, Vogel U. World J Gastroenterol; 2015 Nov 07; 21(41):11862-76. PubMed ID: 26557010 [Abstract] [Full Text] [Related]
4. Expression of ATP-binding cassette membrane transporters in rodent and human sertoli cells: relevance to the permeability of antiretroviral therapy at the blood-testis barrier. Robillard KR, Hoque T, Bendayan R. J Pharmacol Exp Ther; 2012 Jan 07; 340(1):96-108. PubMed ID: 21990609 [Abstract] [Full Text] [Related]
6. Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells. Li S, Lei Y, Jia Y, Li N, Wink M, Ma Y. Phytomedicine; 2011 Dec 15; 19(1):83-7. PubMed ID: 21802927 [Abstract] [Full Text] [Related]
7. The role of efflux transporters on the transport of highly toxic aconitine, mesaconitine, hypaconitine, and their hydrolysates, as determined in cultured Caco-2 and transfected MDCKII cells. Ye L, Yang X, Yang Z, Gao S, Yin T, Liu W, Wang F, Hu M, Liu Z. Toxicol Lett; 2013 Feb 04; 216(2-3):86-99. PubMed ID: 23200901 [Abstract] [Full Text] [Related]
8. Reversal of different drug-resistant phenotypes by an autocatalytic multitarget multiribozyme directed against the transcripts of the ABC transporters MDR1/P-gp, MRP2, and BCRP. Kowalski P, Surowiak P, Lage H. Mol Ther; 2005 Apr 04; 11(4):508-22. PubMed ID: 15771954 [Abstract] [Full Text] [Related]
13. Obatoclax as a perpetrator in drug-drug interactions and its efficacy in multidrug resistance cell lines. Theile D, Allendorf D, Köhler BC, Jassowicz A, Weiss J. J Pharm Pharmacol; 2015 Nov 04; 67(11):1575-84. PubMed ID: 26255619 [Abstract] [Full Text] [Related]
15. Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1. Wang TH, Wan JY, Gong X, Li HZ, Cheng Y. Oncol Rep; 2012 Nov 04; 28(5):1681-6. PubMed ID: 22941407 [Abstract] [Full Text] [Related]
17. Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells. Robey RW, Medina-Pérez WY, Nishiyama K, Lahusen T, Miyake K, Litman T, Senderowicz AM, Ross DD, Bates SE. Clin Cancer Res; 2001 Jan 04; 7(1):145-52. PubMed ID: 11205902 [Abstract] [Full Text] [Related]
18. Differential selectivity of efflux transporter inhibitors in Caco-2 and MDCK-MDR1 monolayers: a strategy to assess the interaction of a new chemical entity with P-gp, BCRP, and MRP2. Mease K, Sane R, Podila L, Taub ME. J Pharm Sci; 2012 May 04; 101(5):1888-97. PubMed ID: 22359351 [Abstract] [Full Text] [Related]
19. A novel 7-modified camptothecin analog overcomes breast cancer resistance protein-associated resistance in a mitoxantrone-selected colon carcinoma cell line. Perego P, De Cesare M, De Isabella P, Carenini N, Beggiolin G, Pezzoni G, Palumbo M, Tartaglia L, Pratesi G, Pisano C, Carminati P, Scheffer GL, Zunino F. Cancer Res; 2001 Aug 15; 61(16):6034-7. PubMed ID: 11507048 [Abstract] [Full Text] [Related]
20. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting. Dahan A, Amidon GL. Am J Physiol Gastrointest Liver Physiol; 2009 Aug 15; 297(2):G371-7. PubMed ID: 19541926 [Abstract] [Full Text] [Related] Page: [Next] [New Search]